Atomoxetine as a Viable ADHD Treatment in Breastfeeding Mothers: Evidence From Human Milk Pharmacokinetic Analysis.

PURPOSE/BACKGROUND: Atomoxetine is a selective norepinephrine reuptake inhibitor prescribed for the management of attention-deficit hyperactivity disorder (ADHD). Untreated ADHD can significantly damage a woman's well-being and often worsens during p…

Preview only. Read the full abstract at the source